LNC Assisted in the Successful Holding of the "ICPO Theranostics FAP Summit" at Germany
Recently, the "ICPO Theranostics FAP Summit-Targeting the Tumor Microenvironment and Beyond" was officially held in Germany. This summit aims to promote innovation in molecular precision oncology therapy in the international field and provide patients with more treatment options. Due to the impact of the COVID-19, the meeting was held in the form of live streaming. As the sponsor of the summit, multiple experts from LNC gave presentations and participated in panel discussions at the summit, including Prof. Chen Xiaoyuan, the Co-founder and Chief Scientist of LNC, and Nasrat Muzayyin Chair Professor in Medicine and Technology, Yong Loo Lin School of Medicine and College of Design and Engineering, National University of Singapore, Dr. Zhang Jingjing, Chief Medical Officer of LNC and Assistant Professor at the National University of Singapore, and Dr. Chen Haojun, Clinical Medical Advisor of LNC. In addition, Dr. Xie Zhiqian, Project Director of DC PHARMA Business Development Department, and Tong Mingyong, Project Director of Business Development Department at Andike Pharmaceutical Group, attended the meeting.
